Here are the top 5 Oncology Nursing News® stories for March 2020.
Here are the top 5 Oncology Nursing News® stories for March 2020.
5. Navigation Helps At-Risk Patients Catch Breast Cancer Earlier
While national guidelines recommend that women at an increased risk of breast cancer undergo additional screening and get extra services, many individuals do not adhere to these recommendations simply because they are unaware of their risk. In this piece, we looked at how a lay navigator can help remedy this problem.
4. Expert Addresses Coronavirus and Cancer Innovation
The novel coronavirus (COVID-19) spreading across the world represents a distinct challenge for all physicians, especially oncologists who commonly treat patients who have compromised immune systems. The spread of the virus was discussed by Scott Gottlieb, MD, during the keynote address at the 37th Annual Miami Breast Cancer Conference®, which we covered in this story.
3. FDA Green Lights Phase III Tocilizumab Trial for COVID-19 Pneumonia
The FDA has approved the examination of oncology supportive care drug tocilizumab (Actemra) for use in combination with standard of care for the treatment of hospitalized adult patients with severe COVID-19 pneumonia. Learn more in this news brief.
2. Nurses, Get to Know Your Patients. It Means More Than You Think
Oncology nurses made it a point to get to know Barbara Bigelow, a breast cancer survivor, while she was getting treatment. In this video, she explains why that made a big difference.
1. NCCN Offers Guidance for Cancer Centers Amid COVID-19 Pandemic
After hearing insight from one of their member institutions, the National Comprehensive Cancer Network shares advice for healthcare providers on the novel COVID-19 pandemic.
Thanks for reading!
Workflow, Educational Tools Improve Use of Silicone Film to Prevent Radiation Dermatitis
April 25th 2024Tools to educate oncology nurses and patients on the use of Mepitel film to prevent radiation dermatitis has improved the workflow around its introduction to patients with breast cancer, as well as its application and maintenance.
Olaparib Plus Chemo May Not Improve Outcomes vs Chemo Alone in BRCA Wild-Type TNBC
April 23rd 2024Patients with BRCA wild-type triple-negative breast cancer treated with olaparib on a gap schedule with chemotherapy did not experience improved responses compared with chemotherapy alone in the neoadjuvant setting.
Nurse Practitioners Weigh in on Data From the San Antonio Breast Cancer Symposium
January 16th 2023Loyda Braithwaite, MSN, RN, AGPCNP-BC, AOCNP; and Jamie Carroll, APRN, CNP, MSN, highlight presentations from the 2022 San Antonio Breast Cancer Symposium that will influence oncology nursing practice.